Oral Lichen Planus: Novel Acquisitions in the Pathogenesis and Treatment
Lichen planus (LP) is a mucocutaneous disease of chronic inflammatory nature, commonly seen in dermatological and dental clinics; it is a relatively common disorder of stratified squamous epithelia, frequently exclusively involving the oral cavity. Oral Lichen Planus (OLP) is often asymptomatic, the...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2013-09-01
|
| Series: | European Journal of Inflammation |
| Online Access: | https://doi.org/10.1177/1721727X1301100304 |
| _version_ | 1811273556105887744 |
|---|---|
| author | R. Saraceno B. Lorè A. Ventura S.P. Nisticò C. Perugia S. Chimenti L. Bianchi |
| author_facet | R. Saraceno B. Lorè A. Ventura S.P. Nisticò C. Perugia S. Chimenti L. Bianchi |
| author_sort | R. Saraceno |
| collection | DOAJ |
| description | Lichen planus (LP) is a mucocutaneous disease of chronic inflammatory nature, commonly seen in dermatological and dental clinics; it is a relatively common disorder of stratified squamous epithelia, frequently exclusively involving the oral cavity. Oral Lichen Planus (OLP) is often asymptomatic, the atrophic-erosive form can cause symptoms ranging from burning sensation to severe pain, interfering with speaking, eating, and swallowing. Lichen planus is regarded as a premalignant lesion. This review discusses the role of hepatitis C virus (HCV), bacterial and fungal infection in LP. Analysing the seroprevalence of HCV infection in LP patients and patients with oral OLP in particular, which was the case in the vast majority of studies, the association varied from 0% to 62% and seemed to be connected to the high HCV seroprevalence in the general population. Candida albicans is present in about 37% of oral LP lesions. The aim of this review is to summarize what is new in the pathogenesis and treatment of OLP. |
| first_indexed | 2024-04-12T23:01:34Z |
| format | Article |
| id | doaj.art-bc8538a2fb42499dae85cf070f9ee703 |
| institution | Directory Open Access Journal |
| issn | 1721-727X |
| language | English |
| last_indexed | 2024-04-12T23:01:34Z |
| publishDate | 2013-09-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | European Journal of Inflammation |
| spelling | doaj.art-bc8538a2fb42499dae85cf070f9ee7032022-12-22T03:13:02ZengSAGE PublishingEuropean Journal of Inflammation1721-727X2013-09-011110.1177/1721727X1301100304Oral Lichen Planus: Novel Acquisitions in the Pathogenesis and TreatmentR. Saraceno0B. Lorè1A. Ventura2S.P. Nisticò3C. Perugia4S. Chimenti5L. Bianchi6 U.O.C. of Dermatology, University of Rome Tor Vergata, Rome, Italy Department of Oral and Maxillo-Facial Surgery, University of Rome Tor Vergata, Rome, Italy U.O.C. of Dermatology, University of Rome Tor Vergata, Rome, Italy Department of Dermatology, University of Catanzaro “Magna Grcecia”, Catanzaro, Italy Department of Paediatric Dentistry, University of Rome Tor Vergata, Rome, Italy U.O.C. of Dermatology, University of Rome Tor Vergata, Rome, Italy U.O.C. of Dermatology, University of Rome Tor Vergata, Rome, ItalyLichen planus (LP) is a mucocutaneous disease of chronic inflammatory nature, commonly seen in dermatological and dental clinics; it is a relatively common disorder of stratified squamous epithelia, frequently exclusively involving the oral cavity. Oral Lichen Planus (OLP) is often asymptomatic, the atrophic-erosive form can cause symptoms ranging from burning sensation to severe pain, interfering with speaking, eating, and swallowing. Lichen planus is regarded as a premalignant lesion. This review discusses the role of hepatitis C virus (HCV), bacterial and fungal infection in LP. Analysing the seroprevalence of HCV infection in LP patients and patients with oral OLP in particular, which was the case in the vast majority of studies, the association varied from 0% to 62% and seemed to be connected to the high HCV seroprevalence in the general population. Candida albicans is present in about 37% of oral LP lesions. The aim of this review is to summarize what is new in the pathogenesis and treatment of OLP.https://doi.org/10.1177/1721727X1301100304 |
| spellingShingle | R. Saraceno B. Lorè A. Ventura S.P. Nisticò C. Perugia S. Chimenti L. Bianchi Oral Lichen Planus: Novel Acquisitions in the Pathogenesis and Treatment European Journal of Inflammation |
| title | Oral Lichen Planus: Novel Acquisitions in the Pathogenesis and Treatment |
| title_full | Oral Lichen Planus: Novel Acquisitions in the Pathogenesis and Treatment |
| title_fullStr | Oral Lichen Planus: Novel Acquisitions in the Pathogenesis and Treatment |
| title_full_unstemmed | Oral Lichen Planus: Novel Acquisitions in the Pathogenesis and Treatment |
| title_short | Oral Lichen Planus: Novel Acquisitions in the Pathogenesis and Treatment |
| title_sort | oral lichen planus novel acquisitions in the pathogenesis and treatment |
| url | https://doi.org/10.1177/1721727X1301100304 |
| work_keys_str_mv | AT rsaraceno orallichenplanusnovelacquisitionsinthepathogenesisandtreatment AT blore orallichenplanusnovelacquisitionsinthepathogenesisandtreatment AT aventura orallichenplanusnovelacquisitionsinthepathogenesisandtreatment AT spnistico orallichenplanusnovelacquisitionsinthepathogenesisandtreatment AT cperugia orallichenplanusnovelacquisitionsinthepathogenesisandtreatment AT schimenti orallichenplanusnovelacquisitionsinthepathogenesisandtreatment AT lbianchi orallichenplanusnovelacquisitionsinthepathogenesisandtreatment |